Abstract
We introduce a model that segments lesions and predicts COVID-19 from chest CT scans through the derivation of an affinity matrix between lesion masks. The novelty of the methodology is based on the computation of the affinity between the lesion masks’ features extracted from the image. First, a batch of vectorized lesion masks is constructed. Then, the model learns the parameters of the affinity matrix that captures the relationship between features in each vector. Finally, the affinity is expressed as a single vector of pre-defined length. Without any complicated data manipulation, class balancing tricks, and using only a fraction of the training data, we achieve a 91.74% COVID-19 sensitivity, 85.35% common pneumonia sensitivity, 97.26% true negative rate and 91.94% F1-score. Ablation studies show that the method can quickly generalize to new datasets. All source code, models and results are publicly available on https://github.com/AlexTS1980/COVID-Affinity-Model.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos